Tricaprilin-13C3

Tricaprilin-13C3 (Trioctanoin-13C3) is a 13C-labeled Tricaprilin (HY-B1804) [1]. Tricaprilin is an orally active and well tolerated ketogenic agent that safely induces ketosis. Tricaprilin restores brain electrical activity and metabolism to help counteract neuroinflammation in migraine. Tricaprilin is promising for research of migraine prevention and Alzheimer’s disease (AD) . Tricaprilin is a pure C8 medium chain triglyceride (MCT) [1][2][3].

Product Specifications

CAS Number

[65402-55-3]

Product Name Alternative

Trioctanoin-13C3; Glyceryl trioctanoate-13C3

UNSPSC

12352211

Hazard Statement

H302

Target

Endogenous Metabolite; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease; Others

Applications

Neuroscience-Neurodegeneration

Field of Research

Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/tricaprilin-13c3.html

Purity

98.0

Smiles

C(CO[13C](CCCCCCC)=O)(CO[13C](CCCCCCC)=O)O[13C](CCCCCCC)=O

Molecular Formula

C24 13C3H50O6

Molecular Weight

473.66

Precautions

H302

References & Citations

[1]Tricaprylin|[2]Kwok MK, et al. Re-thinking Alzheimer's disease therapeutic targets using gene-based tests. EBioMedicine. 2018 Nov;37:461-470.|[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.